Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $94

Benzinga · 2d ago
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $98 to $94.